Botanical Pharmaceuticals Market Poised to Explode

11 Jan 2018
Frankie MacDonald
Administrator / Office Personnel

Industry news

With a projected compound annual growth rate (CAGR) near 8% between 2017 and 2021 in the botanical and plant-derived drugs market, pharmaceutical companies can no longer ignore the high-yield potential found within this explosive industry.

Increase in government initiatives for botanical drug production - Since the FDA declared botanical drugs officially legal in 2004, many government initiatives have followed. The government sees the growing demand and need within the market and has answered with a friendlier regulator environment for botanical drugs and a greater number of awarded contracts to large pharma companies.

Growing demand for treatment options through naturally derived compounds - The increase in natural and holistic health treatment has long been on the uprise, however, both the traditional medical world and the holistic health camp have struggled to find a common ground. Consumer demand has now forced many companies to do just that, and the results are benefitting everyone.

Increase in production efficiency, resulting in lower development costs - With improvements in modern agriculture reaching unprecedented highs, botanical and plant-based drug production has become a large beneficiary of lower costs for development.

Increasingly open foreign markets for the exchange of materials - Hot markets such as China, India and others increasingly offer open exchange for botanical sources and materials used within the botanical drug industry.

Growing limitations on traditional drugs - With the increase in regulatory requirements and greater stringency, it's no wonder the traditional pharmaceutical production has recently experienced a difficult "dry spell". Traditional pharmaceuticals now cost more, take longer, and require greater effort to produce than they ever have.

In short, the market is ready for explosive growth within botanical pharmaceuticals because of a variety of factors that have converged to offer a favorable environment. Make sure your company is positioned to contribute to this growth by outfitting your laboratory with the necessary equipment needed for proper research and development of botanicals.

The Purair® Basic and Advanced Ductless fume hoods, the Purair BIO, and the Purair FLEX are all products that can assist botanical and cannabis manufacturers.

Register now as a free member to get the latest news direct to your inbox >

Links

Tags

Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Plant SciencePlant science studies the biology of plants, including genetics, physiology, ecology, and biotechnology. Research in this field is essential for improving crop yields, disease resistance, and sustainability. Explore plant science tools in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.Drug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.Drug DevelopmentDrug development refers to the process of bringing a new drug to market.